Tim Noffke - Aptinyx VP Staff
| APTXDelisted Stock | USD 0.07 0.01 16.67% |
Insider
Tim Noffke is VP Staff of Aptinyx
| Phone | 847 871 0377 |
| Web | https://www.aptinyx.com |
Aptinyx Management Efficiency
The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Tomasz George | Virax Biolabs Group | 40 | |
| Sumita JD | Instil Bio | 50 | |
| Hoyoung MD | CytomX Therapeutics | 55 | |
| Oleg Nodelman | Nuvation Bio | 44 | |
| Sandeep MD | Instil Bio | 55 | |
| Daniel Welch | Nuvation Bio | 63 | |
| Nicole White | Assembly Biosciences | N/A | |
| Matthew Shatzkes | Aditxt Inc | N/A | |
| Howard MD | ABVC Biopharma | 67 | |
| Alex Lugovoy | Adial Pharmaceuticals | N/A | |
| Uri MD | Assembly Biosciences | 52 | |
| Mark Dudley | Instil Bio | N/A | |
| Susannah Walpole | Spero Therapeutics | N/A | |
| W Vernon | Nuvation Bio | 65 | |
| Catherine Fratila | Adial Pharmaceuticals | N/A | |
| Joan Brown | Allarity Therapeutics | 70 | |
| Mark Peikin | Adial Pharmaceuticals | N/A | |
| Jack Reich | Adial Pharmaceuticals | 75 | |
| TsungShann Jiang | ABVC Biopharma | 70 | |
| Lawrence CPA | Adial Pharmaceuticals | 68 | |
| MHROD SHRMSCP | Assembly Biosciences | N/A | |
Management Performance
| Return On Equity | -1.38 | |||
| Return On Asset | -0.51 |
Aptinyx Leadership Team
Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathryn King, VP Operations | ||
| Norbert Riedel, President CEO, Director | ||
| Patrick Flavin, Sr Relations | ||
| Molly Dir, VP HR | ||
| Ashish Khanna, Chief Business Officer | ||
| Harald MD, VP Affairs | ||
| Tim Noffke, VP Staff | ||
| MD BCh, Pres CEO |
Aptinyx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.38 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (25.91 M) | |||
| Shares Outstanding | 67.72 M | |||
| Shares Owned By Insiders | 13.12 % | |||
| Shares Owned By Institutions | 42.96 % | |||
| Number Of Shares Shorted | 2.23 M | |||
| Price To Earning | (5.61) X | |||
| Price To Book | 0.33 X | |||
| Price To Sales | 45.33 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Aptinyx Stock
If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |